Cessation of Hormone Replacement Therapy After Reports of Adverse Findings From Randomized Controlled Trials: Evidence From a British Birth Cohort
Author(s) -
Gita D. Mishra,
Helen S. Kok,
Russell Ecob,
Rachel Cooper,
Rebecca Hardy,
Diana Kuh
Publication year - 2006
Publication title -
american journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.284
H-Index - 264
eISSN - 1541-0048
pISSN - 0090-0036
DOI - 10.2105/ajph.2005.071332
Subject(s) - medicine , demography , hormone replacement therapy (female to male) , social class , adverse effect , cohort , publicity , obesity , randomized controlled trial , marketing , business , sociology , political science , law , testosterone (patch)
We examined the cessation of hormone replacement therapy (HRT) among British women, by educational level, social class, and cardiovascular risk factors, at the time of publicity about 2 clinical trials of HRT that were halted after adverse findings.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom